Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kerry-Anne Rye

Showing results (11-20 of 270) with videos related to

Pageof 27
Sort By:
The Lancet. Diabetes & Endocrinology|May 31, 2015
HDL function as a predictor of coronary heart disease events: time to re-assess the HDL hypothesis?Kerry-Anne Rye, Kwok Leung Ong
Circulation Research|September 16, 2006
Homocysteine and cardiovascular disease: is HDL the link?Philip J Barter, Kerry-Anne Rye
Arteriosclerosis, Thrombosis, and Vascular Biology|October 24, 2008
Antiinflammatory actions of HDL: a new insightKerry-Anne Rye, Philip J Barter
Circulation Research|January 4, 2014
Regulation of high-density lipoprotein metabolismKerry-Anne Rye, Philip J Barter
Biochimica Et Biophysica Acta|November 5, 2011
Predictive value of different HDL particles for the protection against or risk of coronary heart diseaseKerry-Anne Rye, Philip J Barter
Current Opinion in Lipidology|July 13, 2006
Relationship between the concentration and antiatherogenic activity of high-density lipoproteinsPhilip J Barter, Kerry-Anne Rye
Arteriosclerosis, Thrombosis, and Vascular Biology|February 6, 2016
Cholesteryl Ester Transfer Protein Inhibition Is Not Yet Dead--ProPhilip J Barter, Kerry-Anne Rye
Clinical Therapeutics|November 10, 2015
Targeting High-density Lipoproteins to Reduce Cardiovascular Risk: What Is the Evidence?Philip J Barter, Kerry-Anne Rye
Arteriosclerosis, Thrombosis, and Vascular Biology|August 25, 2007
Is there a role for fibrates in the management of dyslipidemia in the metabolic syndrome?Philip J Barter, Kerry-Anne Rye
Pharmacological Reviews|March 18, 2016
New Era of Lipid-Lowering DrugsPhilip J Barter, Kerry-Anne Rye
Pageof 27

Showing results (11-20 of 270) with videos related to

Sort By:
Pageof 27
The Lancet. Diabetes & Endocrinology|May 31, 2015
HDL function as a predictor of coronary heart disease events: time to re-assess the HDL hypothesis?Kerry-Anne Rye, Kwok Leung Ong
Circulation Research|September 16, 2006
Homocysteine and cardiovascular disease: is HDL the link?Philip J Barter, Kerry-Anne Rye
Arteriosclerosis, Thrombosis, and Vascular Biology|October 24, 2008
Antiinflammatory actions of HDL: a new insightKerry-Anne Rye, Philip J Barter
Circulation Research|January 4, 2014
Regulation of high-density lipoprotein metabolismKerry-Anne Rye, Philip J Barter
Biochimica Et Biophysica Acta|November 5, 2011
Predictive value of different HDL particles for the protection against or risk of coronary heart diseaseKerry-Anne Rye, Philip J Barter
Current Opinion in Lipidology|July 13, 2006
Relationship between the concentration and antiatherogenic activity of high-density lipoproteinsPhilip J Barter, Kerry-Anne Rye
Arteriosclerosis, Thrombosis, and Vascular Biology|February 6, 2016
Cholesteryl Ester Transfer Protein Inhibition Is Not Yet Dead--ProPhilip J Barter, Kerry-Anne Rye
Clinical Therapeutics|November 10, 2015
Targeting High-density Lipoproteins to Reduce Cardiovascular Risk: What Is the Evidence?Philip J Barter, Kerry-Anne Rye
Arteriosclerosis, Thrombosis, and Vascular Biology|August 25, 2007
Is there a role for fibrates in the management of dyslipidemia in the metabolic syndrome?Philip J Barter, Kerry-Anne Rye
Pharmacological Reviews|March 18, 2016
New Era of Lipid-Lowering DrugsPhilip J Barter, Kerry-Anne Rye
Pageof 27